Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Prana Biotechnology Ltd (NQ: PRAN)
2.390 USD  +0.100 (+4.37%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Prana Biotechnology Ltd
 
< Previous 1 2 3 4 5 Next >
Prana Announces Share Purchase Plan Closed
May 03, 2013
from Marketwired News Releases
Prana Announces $5.8 Million R&D Refund
April 04, 2013
from Marketwired News Releases
Prana Provides Clinical Trials Safety and Progress Update
April 03, 2013
Alzheimer's and Huntington Disease Trials on Track Read More
from Marketwired News Releases
Prana Announces Successful A$7 Million Capital Raising
March 27, 2013
from Marketwired News Releases
Prana Details Data Showing That PBT2 Reduces Cognitive Impairment Caused by Tau Protein Accumulation
March 08, 2013
Summary of New Data Presented at the 11th International Conference on Alzheimer's and Parkinson's Disease Read More
from Marketwired News Releases
Best of Drug Manufacturers-Other Industry: Amarin (AMRN), Prana (PRAN), Teva Pharmaceutical (TEVA)
March 07, 2013
category Stocks
from TransWorldNews Current Releases
Best of Drug Manufacturers-Other Industry: Amarin (AMRN), Prana (PRAN), Teva Pharmaceutical (TEVA)
March 07, 2013
category Stocks
from TransWorldNews Current Releases
Prana's PBT434 Inhibits Accumulation of Parkinson's Protein and Subsequent Death of Brain Cells.
March 06, 2013
New Data to Be Presented at the 11th International Conference on Alzheimer's and Parkinson's Disease and the 11th International Basal Ganglia Society Meeting in Eilat, Israel Read More
from Marketwired News Releases
Prana Announces That PBT2 Reduces Cognitive Impairment Caused by Tau Protein Accumulation
March 04, 2013
New Data to Be Presented at the 11th International Conference on Alzheimer's and Parkinson's Disease Read More
from Marketwired News Releases
Prana to Present at Cowen & Company Health Care Conference on March 4th in Boston, MA
February 25, 2013
from Marketwired News Releases
Prana Announces That New York Academy of Sciences eBriefing Is Available Online
January 29, 2013
'Targeting Metals in Alzheimer's and Other Neurodegenerative Diseases' Symposium Read More
from Marketwired News Releases
Prana Completes Recruitment in Huntington Trial
December 19, 2012
6 Month Phase II Study With PBT2 in Huntington Patients Read More
from Marketwired News Releases
Journal of Huntington's Disease Publishes Benefits of PBT2
December 13, 2012
from Marketwired News Releases
Metal Hypothesis for Alzheimer's, Huntington and Other Neurodegenerative Diseases Declared Promising Therapeutic Strategy by Scientists at New York Academy of Sciences Symposium
December 05, 2012
from Marketwired News Releases
Prana Completes Recruitment in Alzheimer's Trial
November 27, 2012
12 Month Phase II Study With PBT2 in Early Alzheimer's Patients Read More
from Marketwired News Releases
Prana to Present at New York Academy of Science Symposium on November 29th
November 20, 2012
"Targeting Metals in Alzheimer's and Other Neurodegenerative Diseases" Read More
from Marketwired News Releases
Prana Provides Huntington Disease Trial Update in Conjunction With the Huntington Study Group Annual Conference
November 14, 2012
from Marketwired News Releases
Prana Biotechnology: Revised Table in 2012 Annual Report
October 08, 2012
from Marketwired News Releases
Prana Announces A$6.0 Million Capital Raising
October 01, 2012
from Marketwired News Releases
Prana Scientist to Participate in Webcast to Discuss Alzheimer's Disease Therapeutics: Recent Setbacks and Emerging Technologies on Monday, October 1
September 28, 2012
from Marketwired News Releases
Prana's PBT2 Clinical Trials Cited as Most Advanced in Addressing Neurodegeneration From the Metal Equilibrium Perspective
September 19, 2012
from Marketwired News Releases
Prana Receives Recommendation to Proceed With Alzheimer's Clinical Trial From Data Safety Monitoring Board (DSMB)
September 12, 2012
from Marketwired News Releases
Prana Shows Significant Promise in the Fight Against Alzheimer's Disease, According to Experts at Celebration of Science Conference
September 10, 2012
from Marketwired News Releases
Prana Scientists to Participate in Panel on Alzheimer's and Other Issues of Aging at Celebration of Science Conference
September 07, 2012
from Marketwired News Releases
Prana's Parkinson's Drug Meets Michael J. Fox Foundation Development Milestone
August 29, 2012
PBT434 Advances Through IND Enabling Studies Read More
from Marketwired News Releases
Prana Provides Clinical Trials Update
August 22, 2012
Alzheimer's and Huntington Disease Trials on Track Read More
from Marketwired News Releases
Prana's PBT2 Presented at the Huntington's Disease Society of America National Convention
June 13, 2012
Prana's 'Reach2HD' Phase II Trial on Track Read More
from Marketwired News Releases
Prana to Present at the UBS Australian Healthcare Conference in Sydney and the Australian Life Science Investment Showcase in New York
June 01, 2012
from Marketwired News Releases
Prana Chief Scientific Advisor to Give Plenary Lecture at Alzheimer's Symposium in Stockholm Featuring New Targets and Drugs
May 09, 2012
Dr. Rudy Tanzi to Discuss PBT2 Trial on Thursday, May 10 Read More
from Marketwired News Releases
Prana Comments on Archives of Neurology Publication Which Highlights Critical Role of Brain Metals in Huntington Disease Progression
May 01, 2012
MGH Team Publishes Data That Supports the Use of PBT2 in Huntington Disease Read More
from Marketwired News Releases
< Previous 1 2 3 4 5 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here